Mechanisms responsible for therapy resistance of acute myelogenous leukemia (AML).
Köhler
T
T
Department of Clinical Chemistry and Pathological Biochemistry, Medical School, University of Leipzig, Germany.
Eller
J
J
Leiblein
S
S
Lassner
D
D
Helbig
W
W
Remke
H
H
Wagner
O
O
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000032:analysis / Q000235:genetics; D018528:ATP-Binding Cassette Transporters / Q000032:analysis / Q000235:genetics; D018952:Antigens, CD34 / Q000032:analysis / Q000235:genetics; D017209:Apoptosis / Q000187:drug effects; D002470:Cell Survival; D015331:Cohort Studies; D018432:Drug Resistance, Multiple; D005858:Germany; D006801:Humans; D007150:Immunohistochemistry; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D009000:Monocytes / Q000378:metabolism; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D009363:Neoplasm Proteins / Q000032:analysis / Q000235:genetics; D010641:Phenotype; D016133:Polymerase Chain Reaction; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000032:analysis / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D018528:ATP-Binding Cassette Transporters; D018952:Antigens, CD34; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D009363:Neoplasm Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D012333:RNA, Messenger